Announcements Trials
Browse Landscape

Status

Not yet recruiting 1Completed 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 59Neoplasms 52Colorectal Neoplasms 27Carcinoma, Non-Small-Cell Lung 23Prostatic Neoplasms 21Lung Neoplasms 18Leukemia, Myeloid, Acute 16Recurrence 15Multiple Myeloma 12Stomach Neoplasms 11Melanoma 11Brain Neoplasms 11Ovarian Neoplasms 10Neoplasm Metastasis 10Motor Activity 10Head and Neck Neoplasms 10Uterine Cervical Neoplasms 9Squamous Cell Carcinoma of Head and Neck 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Pancreatic Neoplasms 9Lymphoma, Non-Hodgkin 9Glioma 9Carcinoma, Renal Cell 9Myelodysplastic Syndromes 7Lymphoma 7Esophageal Neoplasms 7Colonic Neoplasms 7Carcinoma, Hepatocellular 7Lymphoma, Large B-Cell, Diffuse 6Leukemia 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Legius syndrome × 30 days × Clear all
NCT00111384 2026-06-05

Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)

National Institutes of Health Clinical Center (CC)

Completed
313 enrolled
CNS

Legius syndrome, Neurofibroma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡